3M vs Coca-Cola Europacific Partners
3M is a diversified industrials conglomerate managing a massive litigation overhang from its earplugs and PFAS liabilities while trying to reinvigorate organic growth across its materials and electronics businesses, while Coca-Cola Europacific Partners bottles and distributes Coke's brands across Western Europe, Australia, and Indonesia with disciplined execution and a clear volume growth story. Both companies have long histories of returning capital to shareholders through dividends and buybacks and serve as anchor holdings for income-focused portfolios. The 3M vs Coca-Cola Europacific Partners comparison contrasts an industrial compounder navigating legal uncertainty with a consumer staples bottler running a cleaner playbook.
3M is a diversified industrials conglomerate managing a massive litigation overhang from its earplugs and PFAS liabilities while trying to reinvigorate organic growth across its materials and electron...
Why It's Moving
MMM Analysts Lean Buy for 2026 Amid Solid EPS Growth Outlook
- 9 Buy ratings outpace 7 Holds and 2 Sells across 32 analysts, signaling moderate optimism for MMM's turnaround momentum.
- EPS forecasts for fiscal 2026 hit $8.57-$8.73, up 6.3% year-over-year, fueled by 3% organic growth and $2.5B in share repurchases.
- Median targets cluster around $172-$180, implying 20-28% potential rise, driven by margin expansion and new product traction.
CCEP Stock Warning: Why Analysts See -3% Downside Risk
- Valuation multiples have stretched to the upper end of historical ranges, trading at a premium versus the broader food and beverage sector.
- Stock hovers near overbought territory with a P/E ratio of 27.06x, prompting the downgrade despite solid return on invested capital at 9%.
- Analyst highlights unsustainable premium from positive developments like strong Coca-Cola system alignment, tilting risk/reward downward.
MMM Analysts Lean Buy for 2026 Amid Solid EPS Growth Outlook
- 9 Buy ratings outpace 7 Holds and 2 Sells across 32 analysts, signaling moderate optimism for MMM's turnaround momentum.
- EPS forecasts for fiscal 2026 hit $8.57-$8.73, up 6.3% year-over-year, fueled by 3% organic growth and $2.5B in share repurchases.
- Median targets cluster around $172-$180, implying 20-28% potential rise, driven by margin expansion and new product traction.
CCEP Stock Warning: Why Analysts See -3% Downside Risk
- Valuation multiples have stretched to the upper end of historical ranges, trading at a premium versus the broader food and beverage sector.
- Stock hovers near overbought territory with a P/E ratio of 27.06x, prompting the downgrade despite solid return on invested capital at 9%.
- Analyst highlights unsustainable premium from positive developments like strong Coca-Cola system alignment, tilting risk/reward downward.
Discover More Comparisons
3M vs Ambev
3M is a diversified industrial conglomerate rebuilding itself after years of litigation headwinds from Combat Arms earplugs and PFAS liabilities, while Ambev is Latin America's largest brewer with dominant market share in Brazil and a capital-light franchise model that generates strong free cash flow. 3M vs Ambev both have iconic brand portfolios and long dividend histories, but they're navigating very different restructuring and growth challenges. See how their legal exposure, organic volume trends, and earnings quality compare in this analysis.
3M vs Colgate-Palmolive
3M generates revenues across industrial, safety, and health care segments with a patent portfolio that took decades to build, while Colgate-Palmolive wrings growth from toothpaste, pet nutrition, and oral health brands sold in nearly every country on earth. Both are mature consumer and industrial franchises where pricing power and cost discipline separate average from excellent. 3M vs Colgate-Palmolive puts two dividend stalwarts head to head on margin recovery, litigation exposure, and organic growth trajectory.
3M vs Kimberly-Clark
3M has spent years unwinding a diversified industrial conglomerate to sharpen its focus, while Kimberly-Clark runs a tighter consumer staples ship built around tissue, hygiene, and personal care products sold in virtually every global market. Both companies generate enormous free cash flow and have sustained long dividend track records, making them fixtures in income-oriented portfolios. The 3M vs Kimberly-Clark comparison examines how litigation overhang, portfolio transformation, organic volume growth, and pricing power stack up when you pit a restructuring industrial against a steady consumer staples compounder.
Investment Analysis
3M
MMM
Pros
- 3M delivered positive organic sales growth of 1.5% year-over-year in recent quarters, showing improving top-line momentum.
- Adjusted operating margin increased by 290 basis points year-over-year, indicating enhanced profitability and operational efficiency.
- The company raised its full-year 2025 adjusted EPS guidance twice, projecting adjusted profits between $7.95 and $8.05 per share.
Considerations
- GAAP EPS declined 38% year-over-year, reflecting continued challenges under generally accepted accounting principles.
- Operating cash flow was negative $1 billion recently, raising concerns about cash generation despite adjusted free cash flow of $1.3 billion.
- Stock price forecasts suggest a potential decline of up to 7-9% by the end of 2025, indicating market skepticism despite recent earnings beats.
Pros
- Coca-Cola Europacific Partners is the second-largest bottling partner in the Coca-Cola system, covering developed Europe and Asia-Pacific.
- In 2024, it sold approximately 3.9 billion unit cases, representing about 9% of Coca-Cola’s global system volume, illustrating significant market presence.
- The company maintains a solid dividend yield around 2.36%, offering steady income generation potential for investors.
Considerations
- The Coca-Cola Company exerts strong bargaining power over pricing and brand control, limiting CCEP’s pricing flexibility and margins.
- CCEP’s debt-to-equity ratio is relatively high at about 133%, raising leverage and financial risk concerns.
- Operating in mature developed markets, growth prospects may be constrained compared to emerging market competitors.
Related Market Insights
When Competition Dies: The Monopoly Advantage in Modern Markets
Discover the "Only Game In Town" Neme. Invest in market-dominating companies with predictable cash flows, pricing power, and strong dividends. Start with $1 on Nemo.
Aimee Silverwood | Financial Analyst
July 25, 2025
Related Market Insights
When Competition Dies: The Monopoly Advantage in Modern Markets
Discover the "Only Game In Town" Neme. Invest in market-dominating companies with predictable cash flows, pricing power, and strong dividends. Start with $1 on Nemo.
Aimee Silverwood | Financial Analyst
July 25, 2025
3M (MMM) Next Earnings Date
3M's next earnings date is estimated between April 23 and April 28, 2026, with some sources projecting April 28, 2026, based on historical patterns following the Q1 2026 period. This report will cover the first quarter of 2026, succeeding the Q4 2025 earnings released on January 20, 2026. No official date has been confirmed by the company as of now.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
Coca-Cola Europacific Partners (CCEP) is projected to report its next earnings between July 6 and July 15, 2026, covering the first quarter of 2026, based on historical release patterns following the prior report on February 17, 2026. This estimate aligns with the company's typical quarterly cadence, though no official date has been confirmed. Investors should monitor announcements for the precise timing and details.
3M (MMM) Next Earnings Date
3M's next earnings date is estimated between April 23 and April 28, 2026, with some sources projecting April 28, 2026, based on historical patterns following the Q1 2026 period. This report will cover the first quarter of 2026, succeeding the Q4 2025 earnings released on January 20, 2026. No official date has been confirmed by the company as of now.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
Coca-Cola Europacific Partners (CCEP) is projected to report its next earnings between July 6 and July 15, 2026, covering the first quarter of 2026, based on historical release patterns following the prior report on February 17, 2026. This estimate aligns with the company's typical quarterly cadence, though no official date has been confirmed. Investors should monitor announcements for the precise timing and details.
Which Baskets Do They Appear In?
Only Game In Town
These companies have achieved such dominance that they face little to no real competition in their markets. Our analysts have carefully selected businesses with unmatched market power, creating stability and sustained profitability that comes from being the only real choice in their sectors.
Published: June 20, 2025
Explore BasketWhich Baskets Do They Appear In?
Only Game In Town
These companies have achieved such dominance that they face little to no real competition in their markets. Our analysts have carefully selected businesses with unmatched market power, creating stability and sustained profitability that comes from being the only real choice in their sectors.
Published: June 20, 2025
Explore BasketBuy MMM or CCEP in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
